Abcalis GmbH
PrivateLast Round
Grant
Feb 5, 2023
Total Funding Raised
$221,000
Company Overview
Abcalis GmbH operates in Healthcare & Life Sciences and is based in Braunschweig. Its latest recorded funding round was a Grant round in February 2023.
Abcalis GmbH is a biotechnology company that develops and supplies animal-free recombinant monoclonal and multiclonal antibodies for use in life science research and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abcalis GmbH Comparables
Compare Abcalis GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AdipoGen Life Sciences | 81% | |
| Creative Biolabs | 79% | |
| ProteoGenix | 78% |
For institutional investors. Book with your work email.
Abcalis GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 5, 2023 | ||||
| Grant | Nov 1, 2022 | ||||
| Accelerator | Aug 31, 2022 | ||||
| Grant | Mar 30, 2022 | ||||
| Grant | Dec 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abcalis GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Ministry for Economic Affairs and Climate Action | Grant |
| Startup Akademie Wachstum und Innovation | Grant |
| State of Lower Saxony | Accelerator |
| European Social Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 203% MoM.
- Jan 6, 2026
Monthly visitors increased 42% MoM.
For institutional investors. Book with your work email.
Abcalis GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abcalis GmbH's valuation, stock price, and market status.
Is Abcalis GmbH a public or private company?
Abcalis GmbH is a private company.
What is the current stock price of Abcalis GmbH?
Abcalis GmbH is a private company, so its shares have no public market price. Caplight tracks Abcalis GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abcalis GmbH worth (valuation)?
Valuation information for Abcalis GmbH is not publicly available.
Can I buy Abcalis GmbH stock?
Abcalis GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abcalis GmbH's last funding round?
Abcalis GmbH's most recent funding round was Grant on February 5, 2023.
Who are the main investors in Abcalis GmbH?
Key investors in Abcalis GmbH include Federal Ministry for Economic Affairs and Climate Action, Startup Akademie Wachstum und Innovation, State of Lower Saxony, European Social Fund.
Will Abcalis GmbH IPO soon?
No public IPO plans have been announced for Abcalis GmbH.
How can I track Abcalis GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Abcalis GmbH's shares on secondary markets.